Apolipoprotein B and Cardiovascular Disease: Biomarker and Potential Therapeutic Target
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Apolipoprotein B and Cardiovascular Disease: Biomarker and Potential Therapeutic Target
Authors
Keywords
-
Journal
Metabolites
Volume 11, Issue 10, Pages 690
Publisher
MDPI AG
Online
2021-10-11
DOI
10.3390/metabo11100690
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Conventional and Novel Lipid Measures and Risk of Peripheral Artery Disease
- (2021) Minghao Kou et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- New Insights Into the Regulation of Lipoprotein Metabolism by PCSK9: Lessons From Stable Isotope Tracer Studies in Human Subjects
- (2021) Qidi Ying et al. Frontiers in Physiology
- Low-density lipoprotein cholesterol-to-apolipoprotein B ratio as a potential indicator of LDL particle size and plasma atherogenicity in type 2 diabetes
- (2021) Alena Viktorinova et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Inclisiran
- (2021) Bruce A. Warden et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- The LDL-C/ApoB ratio predicts major cardiovascular events in patients with established atherosclerotic cardiovascular disease
- (2021) Heinz Drexel et al. ATHEROSCLEROSIS
- Efficacy and Safety of Evinacumab for the Treatment of Hypercholesterolemia: A Meta-Analysis
- (2021) Menglong Jin et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Familial Hypercholesterolemia: Global Burden and Approaches
- (2021) Lale Tokgozoglu et al. Current Cardiology Reports
- Evinacumab for treatment of familial hypercholesterolemia
- (2021) Bruce A. Warden et al. Expert Review of Cardiovascular Therapy
- Population pharmacokinetics and exposure–response modeling for evinacumab in homozygous familial hypercholesterolemia
- (2021) Xia Pu et al. CPT-Pharmacometrics & Systems Pharmacology
- Small Dense LDL Tied to Diabetic Retinopathy-Similarity to Atherosclerosis
- (2021) Tsutomu Hirano Journal of Atherosclerosis and Thrombosis
- Metabolic Properties of Lowdensity Lipoprotein (LDL) Triglycerides in Patients with Type 2 Diabetes, Comparison with Small Dense LDL-Cholesterol
- (2021) Tsutomu Hirano et al. Journal of Atherosclerosis and Thrombosis
- Effect of alirocumab on individuals with type 2 diabetes, high triglycerides, and low high-density lipoprotein cholesterol
- (2020) Helen M. Colhoun et al. Cardiovascular Diabetology
- Pharmacological aspects of ANGPTL3 and ANGPTL4 inhibitors: New therapeutic approaches for the treatment of atherogenic dyslipidemia
- (2020) Massimiliano Ruscica et al. PHARMACOLOGICAL RESEARCH
- Pharmacokinetics of current and emerging treatments for hypercholesterolemia
- (2020) Brian Tomlinson et al. Expert Opinion on Drug Metabolism & Toxicology
- LDL subclass lipidomics in atherogenic dyslipidemia: effect of statin therapy on bioactive lipids and dense LDL
- (2020) M. John Chapman et al. JOURNAL OF LIPID RESEARCH
- Patient Characteristics and Treatment Patterns among Medicare Beneficiaries Initiating PCSK9 Inhibitor Therapy
- (2020) Xue Feng et al. CARDIOVASCULAR DRUGS AND THERAPY
- Prognostic significance of carotid plaque‐presence in peritoneal dialysis patients and its association with the apolipoprotein B/apolipoprotein A1 ratio
- (2020) Yun Chen et al. NEPHROLOGY
- Non-HDL Cholesterol or apoB: Which to Prefer as a Target for the Prevention of Atherosclerotic Cardiovascular Disease?
- (2020) Michel R. Langlois et al. Current Cardiology Reports
- Accuracy of Pulse Wave Velocity Predicting Cardiovascular and All-Cause Mortality. A Systematic Review and Meta-Analysis
- (2020) Irene Sequí-Domínguez et al. Journal of Clinical Medicine
- Towards an SI-Traceable Reference Measurement System for Seven Serum Apolipoproteins Using Bottom-Up Quantitative Proteomics: Conceptual Approach Enabled by Cross-Disciplinary/Cross-Sector Collaboration
- (2020) Christa M Cobbaert et al. CLINICAL CHEMISTRY
- Low-density lipoprotein cholesterol/apolipoprotein B ratio is superior to apolipoprotein B alone in the diagnosis of coronary artery calcification
- (2020) Tsui-Yen Chang et al. CORONARY ARTERY DISEASE
- Efficacy and safety of bempedoic acid alone or combining with other lipid-lowering therapies in hypercholesterolemic patients: a meta-analysis of randomized controlled trials
- (2020) Xiang Zhao et al. BMC Pharmacology & Toxicology
- Apolipoprotein B correlates with intra-plaque necrotic core volume in stable coronary artery disease
- (2019) Takayuki Ohwada et al. PLoS One
- Safety and Efficacy of Bempedoic Acid to Reduce LDL Cholesterol
- (2019) Kausik K. Ray et al. NEW ENGLAND JOURNAL OF MEDICINE
- 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary
- (2019) Donna K. Arnett et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Association of Triglyceride-Lowering LPL Variants and LDL-C–Lowering LDLR Variants With Risk of Coronary Heart Disease
- (2019) Brian A. Ference et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Lipidomics of Bioactive Lipids in Acute Coronary Syndromes
- (2019) Zahra Solati et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Heart Disease and Stroke Statistics—2019 Update: A Report From the American Heart Association
- (2019) Emelia J. Benjamin et al. CIRCULATION
- ApoB
- (2019) Allan D. Sniderman et al. CIRCULATION RESEARCH
- Efficacy and Safety of Mipomersen: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
- (2019) Federica Fogacci et al. DRUGS
- BMI modifies the effect of dietary fat on atherogenic lipids: a randomized clinical trial
- (2019) Tine Mejlbo Sundfør et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Keep recycling going: New approaches to reduce LDL-C
- (2019) Andres J.P. Klein-Szanto et al. BIOCHEMICAL PHARMACOLOGY
- Extreme Atherosclerotic Cardiovascular Disease (ASCVD) Risk Recognition
- (2019) Paul D. Rosenblit Current Diabetes Reports
- Global Updates on Cardiovascular Disease Mortality Trends and Attribution of Traditional Risk Factors
- (2019) Ram Jagannathan et al. Current Diabetes Reports
- Mechanistic Insights to Target Atherosclerosis Residual Risk
- (2019) Mohammad Alkhalil CURRENT PROBLEMS IN CARDIOLOGY
- Vaccination against atherosclerosis: An overview
- (2019) Hamideh Amirfakhryan Hellenic Journal of Cardiology
- Elevated apolipoprotein B as a risk-enhancing factor in 2018 cholesterol guidelines
- (2019) Scott M. Grundy et al. Journal of Clinical Lipidology
- Effects of weight change on apolipoprotein B-containing emerging atherosclerotic cardiovascular disease (ASCVD) risk factors
- (2019) Michael L. Dansinger et al. Lipids in Health and Disease
- Serious Adverse Effects of Extended-release Niacin/Laropiprant: Results From the Heart Protection Study 2–Treatment of HDL to Reduce the Incidence of Vascular Events (HPS2-THRIVE) Trial
- (2019) Richard Haynes et al. CLINICAL THERAPEUTICS
- Vaccination against atherosclerosis
- (2019) Kouji Kobiyama et al. CURRENT OPINION IN IMMUNOLOGY
- Non-HDL cholesterol should not generally replace LDL cholesterol in the management of hyperlipidaemia
- (2019) Handrean Soran et al. CURRENT OPINION IN LIPIDOLOGY
- 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk
- (2019) François Mach et al. EUROPEAN HEART JOURNAL
- The crystal structure of human microsomal triglyceride transfer protein
- (2019) Ekaterina I. Biterova et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Microsomal triglyceride transfer protein inhibitor (lomitapide) efficacy in the treatment of patients with homozygous familial hypercholesterolaemia
- (2019) Genovefa Kolovou et al. European Journal of Preventive Cardiology
- Comparison of Apolipoprotein B/A1 ratio, Framingham risk score and TC/HDL-c for predicting clinical outcomes in patients undergoing percutaneous coronary intervention
- (2019) Min Tian et al. Lipids in Health and Disease
- Novel and traditional lipid profiles in Metabolic Syndrome reveal a high atherogenicity
- (2019) Sílvia Paredes et al. Scientific Reports
- Impact of the Martin/Hopkins modified equation for estimating LDL-C on lipid target attainment in a high risk patient population
- (2019) Louis-Jacques Cartier et al. CLINICAL BIOCHEMISTRY
- Quantifying atherogenic lipoproteins for lipid-lowering strategies: consensus-based recommendations from EAS and EFLM
- (2019) Michel R. Langlois et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Endoplasmic reticulum quality control in lipoprotein metabolism
- (2019) Cari M. Koerner et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Preventive Pharmacotherapy for Cardiovascular Disease: A Modelling Study Considering Health Gain, Costs, and Cost-Effectiveness when Stratifying by Absolute Risk
- (2019) Nhung Nghiem et al. Scientific Reports
- Comparative Trends in Heart Disease, Stroke, and All-Cause Mortality in the United States and a Large Integrated Healthcare Delivery System
- (2018) Stephen Sidney et al. AMERICAN JOURNAL OF MEDICINE
- Can modulators of apolipoproteinB biogenesis serve as an alternate target for cholesterol-lowering drugs?
- (2018) Lynley M. Doonan et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Projected Costs of Informal Caregiving for Cardiovascular Disease: 2015 to 2035: A Policy Statement From the American Heart Association
- (2018) Sandra B. Dunbar et al. CIRCULATION
- LDL-Reactive T Cells Regulate Plasma Cholesterol Levels and Development of Atherosclerosis in Humanized Hypercholesterolemic Mice
- (2018) Anton Gisterå et al. CIRCULATION
- PCSK9 in cholesterol metabolism: from bench to bedside
- (2018) Allison B. Reiss et al. CLINICAL SCIENCE
- Fasting or Non-fasting Lipids for Atherosclerotic Cardiovascular Disease Risk Assessment and Treatment?
- (2018) Faisal Rahman et al. Current Atherosclerosis Reports
- Plasma apolipoprotein-B is an important risk factor for cardiovascular disease, and its assessment should be routine clinical practice
- (2018) Stella Trompet et al. CURRENT OPINION IN LIPIDOLOGY
- Apolipoprotein B measurement: Need for standardization
- (2018) John H. Contois et al. Journal of Clinical Lipidology
- A comparison of three apolipoprotein B methods and their associations with incident coronary heart disease risk over a 12-year follow-up period: The Multi-Ethnic Study of Atherosclerosis
- (2018) Jing Cao et al. Journal of Clinical Lipidology
- Lipid transfer proteins in the assembly of apoB-containing lipoproteins
- (2018) Alaa Sirwi et al. JOURNAL OF LIPID RESEARCH
- Effects of Anacetrapib in Patients With Atherosclerotic Vascular Disease
- (2018) L. Bowman et al. JOURNAL OF VASCULAR SURGERY
- Discordance between lipoprotein particle number and cholesterol content
- (2018) Eric P. Cantey et al. Current Opinion in Endocrinology Diabetes and Obesity
- Comparability of Lipoprotein Particle Number Concentrations Across ES-DMA, NMR, LC-MS/MS, Immunonephelometry, and VAP: In Search of a Candidate Reference Measurement Procedure for apoB and non-HDL-P Standardization
- (2018) Vincent Delatour et al. CLINICAL CHEMISTRY
- Lipoprotein Sub-Fractions by Ion-Mobility Analysis and Its Association with Subclinical Coronary Atherosclerosis in High-Risk Individuals
- (2018) Ehimen C Aneni et al. Journal of Atherosclerosis and Thrombosis
- The Spectrum of Type III Hyperlipoproteinemia
- (2018) Allan D. Sniderman et al. Journal of Clinical Lipidology
- Cardiovascular events in patients under age fifty with early findings of elevated lipid and glucose levels – The AMORIS study
- (2018) Torbjörn Ivert et al. PLoS One
- Foam cell formation: A new target for fighting atherosclerosis and cardiovascular disease
- (2018) Eithne M. Maguire et al. VASCULAR PHARMACOLOGY
- Recent Advances in the Development of Vaccines for Diabetes, Hypertension, and Atherosclerosis
- (2018) Kongye Lu et al. Journal of Diabetes Research
- Removal of Chylomicron Remnants from the Bloodstream is Delayed in Aged Subjects
- (2018) Carmen G Vinagre et al. Aging and Disease
- Is Anacetrapib Better Than Its CETP Inhibitor Counterparts?
- (2018) Mordechai Grabie et al. Cardiology in Review
- In Pursuit of an Atherosclerosis Vaccine
- (2018) Kuang-Yuh Chyu et al. CIRCULATION RESEARCH
- Apolipoproteins A1, B, and apoB/apoA1 ratio are associated with first ST-segment elevation myocardial infarction but not with recurrent events during long-term follow-up
- (2018) Mathijs C. Bodde et al. Clinical Research in Cardiology
- Mendelian randomization reveals unexpected effects of CETP on the lipoprotein profile
- (2018) Lisanne L. Blauw et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
- (2018) Gregory G. Schwartz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Non-HDL-cholesterol and apolipoprotein B compared with LDL-cholesterol in atherosclerotic cardiovascular disease risk assessment
- (2018) Stuart S. Carr et al. PATHOLOGY
- Erythrocyte-bound apolipoprotein B in atherosclerosis and mortality
- (2017) Marijke A. de Vries et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Association of Genetic Variants Related to CETP Inhibitors and Statins With Lipoprotein Levels and Cardiovascular Risk
- (2017) Brian A. Ference et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Apolipoprotein B vs non–high-density lipoprotein cholesterol: Association with endothelial hemostatic markers and carotid intima-media thickness
- (2017) David Karasek et al. Journal of Clinical Lipidology
- ApoB-lipoproteins and dysfunctional white adipose tissue: Relation to risk factors for type 2 diabetes in humans
- (2017) Valérie Lamantia et al. Journal of Clinical Lipidology
- Prediction of future cardiovascular disease with an equation to estimate apolipoprotein B in patients with high cardiovascular risk: an analysis from the TNT and IDEAL study
- (2017) You-Cheol Hwang et al. Lipids in Health and Disease
- CETP Inhibitors — A New Inning?
- (2017) Robert A. Hegele NEW ENGLAND JOURNAL OF MEDICINE
- Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease
- (2017) Marc S. Sabatine et al. NEW ENGLAND JOURNAL OF MEDICINE
- Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease
- (2017) A. Michael Lincoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Small Dense Low-Density Lipoprotein as Biomarker for Atherosclerotic Diseases
- (2017) Ekaterina A. Ivanova et al. Oxidative Medicine and Cellular Longevity
- Dietary strategies for cardiovascular health
- (2017) Brad P. Dieter et al. TRENDS IN CARDIOVASCULAR MEDICINE
- Cardiovascular Risk Assessment
- (2016) Mohammed Y. Khanji et al. ANNALS OF INTERNAL MEDICINE
- Metabolism and Modification of Apolipoprotein B-Containing Lipoproteins Involved in Dyslipidemia and Atherosclerosis
- (2016) Shin-ya Morita BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Should apolipoprotein B replace LDL cholesterol as therapeutic targets are lowered?
- (2016) Jeffrey W. Meeusen et al. CURRENT OPINION IN LIPIDOLOGY
- Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions
- (2016) Michael G. Silverman et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- VLDL Triglyceride Kinetics in Lean, Overweight, and Obese Men and Women
- (2016) Bettina Mittendorfer et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Discordance Between Apolipoprotein B and LDL-Cholesterol in Young Adults Predicts Coronary Artery Calcification
- (2016) John T. Wilkins et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Determining When to Add Nonstatin Therapy
- (2016) Jennifer G. Robinson et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Nutritional management of hyperapoB
- (2016) Valérie Lamantia et al. NUTRITION RESEARCH REVIEWS
- Age and Cardiovascular Risk Attributable to Apolipoprotein B, Low‐Density Lipoprotein Cholesterol or Non‐High‐Density Lipoprotein Cholesterol
- (2016) Allan D. Sniderman et al. Journal of the American Heart Association
- Risk of Premature Cardiovascular Disease vs the Number of Premature Cardiovascular Events
- (2016) Allan D. Sniderman et al. JAMA Cardiology
- Recent Trends in Cardiovascular Mortality in the United States and Public Health Goals
- (2016) Stephen Sidney et al. JAMA Cardiology
- The New Pooled Cohort Equations Risk Calculator
- (2015) David Preiss et al. CANADIAN JOURNAL OF CARDIOLOGY
- Apolipoprotein B, the villain in the drama?
- (2015) Qi Yu et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Dabigatran and apolipoprotein B
- (2015) Hugo ten Cate HEART
- Dabigatran etexilate and reduction in serum apolipoprotein B
- (2015) Philip Joseph et al. HEART
- Discordance between apolipoprotein B and low-density lipoprotein particle number is associated with insulin resistance in clinical practice
- (2015) Stephen A. Varvel et al. Journal of Clinical Lipidology
- 10-Year Coronary Heart Disease Risk Prediction Using Coronary Artery Calcium and Traditional Risk Factors
- (2015) Robyn L. McClelland et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Demographic and Epidemiologic Drivers of Global Cardiovascular Mortality
- (2015) Gregory A. Roth et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of Extended‐Release Niacin on High‐Density Lipoprotein (HDL) Functionality, Lipoprotein Metabolism, and Mediators of Vascular Inflammation in Statin‐Treated Patients
- (2015) Rahul Yadav et al. Journal of the American Heart Association
- Kinetic Studies to Elucidate Impaired Metabolism of Triglyceride-rich Lipoproteins in Humans
- (2015) Martin Adiels et al. Frontiers in Physiology
- Apolipoprotein B and non-HDL cholesterol are more powerful predictors for incident type 2 diabetes than fasting glucose or glycated hemoglobin in subjects with normal glucose tolerance: a 3.3-year retrospective longitudinal study
- (2014) You-Cheol Hwang et al. ACTA DIABETOLOGICA
- Mipomersen is a Promising Therapy in the Management of Hypercholesterolemia: A Meta-Analysis of Randomized Controlled Trials
- (2014) Na Li et al. American Journal of Cardiovascular Drugs
- Significant associations between lipoprotein(a) and corrected apolipoprotein B-100 levels in African–Americans
- (2014) Byambaa Enkhmaa et al. ATHEROSCLEROSIS
- Impact of statin adherence on cardiovascular disease and mortality outcomes: a systematic review
- (2014) Mary A. De Vera et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Novel unbiased equations to calculate triglyceride-rich lipoprotein cholesterol from routine non-fasting lipids
- (2014) Michel P Hermans et al. Cardiovascular Diabetology
- Inflammation and its Resolution as Determinants of Acute Coronary Syndromes
- (2014) Peter Libby et al. CIRCULATION RESEARCH
- The composition and metabolism of large and small LDL
- (2014) Margaret R. Diffenderfer et al. CURRENT OPINION IN LIPIDOLOGY
- Gestational Diabetes and the Metabolic Syndrome: Can Obesity and Small, Dense Low Density Lipoproteins be Key Mediators of this Association?
- (2014) Ali Rizvi et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- Absolute quantification of apolipoproteins and associated proteins on human plasma lipoproteins
- (2014) Anne von Zychlinski et al. Journal of Proteomics
- Very Low Levels of Atherogenic Lipoproteins and the Risk for Cardiovascular Events
- (2014) S. Matthijs Boekholdt et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- LDL cholesterol: controversies and future therapeutic directions
- (2014) Paul M Ridker LANCET
- New Therapies Targeting apoB Metabolism for High-Risk Patients with Inherited Dyslipidaemias: What Can the Clinician Expect?
- (2013) Amirhossein Sahebkar et al. CARDIOVASCULAR DRUGS AND THERAPY
- Systematic Review: Evaluating the Effect of Lipid-Lowering Therapy on Lipoprotein and Lipid Values
- (2013) Robert S. Rosenson et al. CARDIOVASCULAR DRUGS AND THERAPY
- 2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk
- (2013) David C. Goff et al. CIRCULATION
- ApoB versus non-HDL-cholesterol: Diagnosis and cardiovascular risk management
- (2013) Tjerk de Nijs et al. CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES
- Cardiovascular Disease in Diabetes Mellitus
- (2013) Magdalene M. Szuszkiewicz-Garcia et al. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA
- Discordance between high non-HDL cholesterol and high LDL-cholesterol among US adults
- (2013) Meredith Kilgore et al. Journal of Clinical Lipidology
- 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults
- (2013) Neil J. Stone et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Consistency of Extended-Release Niacin/Laropiprant Effects on Lp(a), ApoB, non-HDL-C, Apo A1, and ApoB/ApoA1 Ratio Across Patient Subgroups
- (2012) Harold E. Bays et al. American Journal of Cardiovascular Drugs
- Intracellular Trafficking and Secretion of VLDL
- (2012) Samata Tiwari et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- The Pharmacology and Therapeutic Use of Dabigatran Etexilate
- (2012) Spinler Sarah JOURNAL OF CLINICAL PHARMACOLOGY
- Effects of Dalcetrapib in Patients with a Recent Acute Coronary Syndrome
- (2012) Gregory G. Schwartz et al. NEW ENGLAND JOURNAL OF MEDICINE
- An Equation to Estimate the Concentration of Serum Apolipoprotein B
- (2012) You-Cheol Hwang et al. PLoS One
- Non-HDL-cholesterol as valid surrogate to apolipoprotein B100 measurement in diabetes: Discriminant Ratio and unbiased equivalence
- (2011) Michel P Hermans et al. Cardiovascular Diabetology
- A Meta-Analysis of Low-Density Lipoprotein Cholesterol, Non-High-Density Lipoprotein Cholesterol, and Apolipoprotein B as Markers of Cardiovascular Risk
- (2011) Allan D. Sniderman et al.
- Postprandial lipoprotein metabolism: VLDL vs chylomicrons
- (2011) Katsuyuki Nakajima et al. CLINICA CHIMICA ACTA
- Residual Cardiovascular Risk Despite Optimal LDL Cholesterol Reduction with Statins: The Evidence, Etiology, and Therapeutic Challenges
- (2011) Uchechukwu K. Sampson et al. Current Atherosclerosis Reports
- “European Panel On Low Density Lipoprotein (LDL) Subclasses”: A Statement on the Pathophysiology, Atherogenicity and Clinical Significance of LDL Subclasses: Executive Summary
- (2011) Dimitri P. Mikhailidis et al. Current Vascular Pharmacology
- Effects of coadministered extended-release niacin/laropiprant and simvastatin on lipoprotein subclasses in patients with dyslipidemia
- (2011) Christie Ballantyne et al. Journal of Clinical Lipidology
- Antisense oligonucleotide reduction of apoB-ameliorated atherosclerosis in LDL receptor-deficient mice
- (2011) Adam E. Mullick et al. JOURNAL OF LIPID RESEARCH
- High-fat meal effect on LDL, HDL, and VLDL particle size and number in the Genetics of Lipid-Lowering drugs and diet network (GOLDN): an interventional study
- (2011) Mary K Wojczynski et al. Lipids in Health and Disease
- Intranasal Immunization With an Apolipoprotein B-100 Fusion Protein Induces Antigen-Specific Regulatory T Cells and Reduces Atherosclerosis
- (2010) Roland Klingenberg et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Apolipoprotein C-III and the Metabolic Basis for Hypertriglyceridemia and the Dense Low-Density Lipoprotein Phenotype
- (2010) Chunyu Zheng et al. CIRCULATION
- Executive Summary: Heart Disease and Stroke Statistics—2010 Update
- (2010) et al. CIRCULATION
- Association of Apolipoprotein B with Incident Type 2 Diabetes in an Aboriginal Canadian Population
- (2010) S. H. Ley et al. CLINICAL CHEMISTRY
- Role of fibrates in cardiovascular disease prevention, the ACCORD-Lipid perspective
- (2010) Marshall Elam et al. CURRENT OPINION IN LIPIDOLOGY
- Caloric Sweetener Consumption and Dyslipidemia Among US Adults
- (2010) Jean A. Welsh JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Functions of cholesterol ester transfer protein and relationship to coronary artery disease risk
- (2010) Alan R. Tall Journal of Clinical Lipidology
- Apolipoprotein B, non-HDL cholesterol and LDL cholesterol for identifying individuals at increased cardiovascular risk
- (2010) S. Holewijn et al. JOURNAL OF INTERNAL MEDICINE
- Recent progress in understanding protein and lipid factors affecting hepatic VLDL assembly and secretion
- (2010) Meenakshi Sundaram et al. Nutrition & Metabolism
- Thirty-One Novel Biomarkers as Predictors for Clinically Incident Diabetes
- (2010) Veikko Salomaa et al. PLoS One
- Mechanisms Targeting Apolipoprotein B100 to Proteasomal Degradation
- (2009) Angela C. Rutledge et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Small, dense LDL cholesterol and apolipoprotein B: Relationship with serum lipids and LDL size
- (2009) Jelena Vekic et al. ATHEROSCLEROSIS
- Atherogenic lipoprotein phenotype and LDL size and subclasses in drug-naïve patients with early rheumatoid arthritis
- (2009) Manfredi Rizzo et al. ATHEROSCLEROSIS
- Relationship of Oxidized Phospholipids on Apolipoprotein B-100 Particles to Race/Ethnicity, Apolipoprotein(a) Isoform Size, and Cardiovascular Risk Factors
- (2009) Sotirios Tsimikas et al. CIRCULATION
- Apolipoprotein B and Cardiovascular Disease Risk: Position Statement from the AACC Lipoproteins and Vascular Diseases Division Working Group on Best Practices
- (2009) J. H. Contois et al. CLINICAL CHEMISTRY
- Apolipoprotein B but not LDL Cholesterol Is Associated With Coronary Artery Calcification in Type 2 Diabetic Whites
- (2009) S. S. Martin et al. DIABETES
- The Residual Risk Reduction Initiative: A Call to Action to Reduce Residual Vascular Risk in Patients with Dyslipidemia
- (2008) Jean-Charles Fruchart et al. AMERICAN JOURNAL OF CARDIOLOGY
- Gender-Specific Differences in the Kinetics of Nonfasting TRL, IDL, and LDL Apolipoprotein B-100 in Men and Premenopausal Women
- (2008) Nirupa R. Matthan et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Cholesteryl Ester Transfer Protein Inhibition, High-Density Lipoprotein Raising, and Progression of Coronary Atherosclerosis
- (2008) Stephen J. Nicholls et al. CIRCULATION
- General Cardiovascular Risk Profile for Use in Primary Care
- (2008) Ralph B. D’Agostino et al. CIRCULATION
- Atherogenic lipoprotein phenotype and LDL size and subclasses in women with gestational diabetes
- (2008) M. Rizzo et al. DIABETIC MEDICINE
- Concentration of apolipoprotein B is comparable with the apolipoprotein B/apolipoprotein A-I ratio and better than routine clinical lipid measurements in predicting coronary heart disease mortality: findings from a multi-ethnic US population
- (2008) J. Sierra-Johnson et al. EUROPEAN HEART JOURNAL
- High plasma concentrations of autoantibodies against native peptide 210 of apoB-100 are related to less coronary atherosclerosis and lower risk of myocardial infarction
- (2008) P. Sjogren et al. EUROPEAN HEART JOURNAL
- Lipid-modifying efficacy and tolerability of extended-release niacin/laropiprant in patients with primary hypercholesterolaemia or mixed dyslipidaemia
- (2008) D. Maccubbin et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Relationships between lipoprotein components and risk of myocardial infarction: age, gender and short versus longer follow-up periods in the Apolipoprotein MOrtality RISk study (AMORIS)
- (2008) I. Holme et al. JOURNAL OF INTERNAL MEDICINE
- Reconstituting Initial Events during the Assembly of Apolipoprotein B-Containing Lipoproteins in a Cell-Free System
- (2008) Z. Gordon Jiang et al. JOURNAL OF MOLECULAR BIOLOGY
- Effects of Laropiprant on Nicotinic Acid-Induced Flushing in Patients With Dyslipidemia††A list of study investigators appears in the Appendix.
- (2007) John F. Paolini et al. AMERICAN JOURNAL OF CARDIOLOGY
- Atherogenic lipoprotein phenotype and LDL size and subclasses in patients with peripheral arterial disease
- (2007) Manfredi Rizzo et al. ATHEROSCLEROSIS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started